Fetal lung interstitial tumor: A cause of late gestation fetal hydrops

Journal of Pediatric Surgery

Volumn 46, Issue 6, 2011, Pages 1263-1266

  Lazar, David A ^a   Cass, Darrell L ^a   Dishop, Megan K ^b   Adam, Karolina ^a   Olutoye, Olutoyin A ^a   Ayres, Nancy A ^a   Cassady, Christopher I ^a   Olutoye, Oluyinka O ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Ex utero intrapartum therapy; Fetal lung interstitial tumor; Fetal lung mass; Hydrops; Immature mesenchymal interstitial tumor; Pleuropulmonary blastoma

Indexed keywords

ADULT; AIR CONDITIONING; ARTICLE; CASE REPORT; CESAREAN SECTION; DECOMPRESSION; ECHOCARDIOGRAPHY; EX UTERO INTRAPARTUM TREATMENT; FEMALE; FETAL LUNG INTERSTITIAL TUMOR; FETAL MAGNETIC RESONANCE IMAGING; FETAL TUMOR; FETUS; FETUS HYDROPS; FETUS LUNG; FOLLOW UP; GESTATIONAL AGE; HEART FAILURE; HISTOPATHOLOGY; HUMAN; HYSTEROTOMY; INFERIOR CAVA VEIN; LUNG MALFORMATION; LUNG TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PARACENTESIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; SUPERIOR CAVA VEIN; THIRD TRIMESTER PREGNANCY; THORAX RADIOGRAPHY; UTERUS FUNDUS HEIGHT;

ADULT; DELIVERY, OBSTETRIC; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROPS FETALIS; INFANT, NEWBORN; LEYDIG CELL TUMOR; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; PRENATAL CARE; PRENATAL DIAGNOSIS; RARE DISEASES; RISK ASSESSMENT; TREATMENT OUTCOME; ULTRASONOGRAPHY, PRENATAL;

EID: 79959301018     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2011.02.056     Document Type: Article

References (17)

1. Stocker JT, Madewell JE, Drake RM. Congenital cystic adenomatoid malformation of the lung. Classification and morphologic spectrum. Hum Pathol 1977;8:155-71.
2. Stocker JT. Cystic lung disease in infants and children. Fetal Pediatr Pathol 2009;28:155-84.
3. Langston C. New concepts in the pathology of congenital lung malformations. Semin Pediatr Surg 2003;12:17-37. (Pubitemid 36182794)
4. Cass DL, Olutoye OO, Cassady CI, et al. Prenatal diagnosis and outcome of fetal lung masses. J Pediatr Surg 2011;46:292-8.
5. Kunisaki SM, Barnewolt CE, Estroff JA, et al. Large fetal congenital cystic adenomatoid malformations: growth trends and patient survival. J Pediatr Surg 2007;42:404-10. (Pubitemid 46161568)
6. Adzick NS: Management of fetal lung lesions. Clin Perinatol 2009;36:363-76.
7. Miniati DN, Chintagumpala M, Langston C, et al. Prenatal presentation and outcome of children with pleuropulmonary blastoma. J Pediatr Surg 2006;41:66-71. (Pubitemid 43067494)
8. Crombleholme TM, Coleman B, Hedrick H, et al. Cystic adenomatoid malformation volume ratio predicts outcome in prenatally diagnosed cystic adenomatoid malformation of the lung. J Pediatr Surg 2002;37:331-8. (Pubitemid 34188149)
9. Lazar DA, Olutoye OO, Moise KJ, et al. Ex-Utero intrapartum treatment (EXIT) procedure for giant neck masses - fetal and maternal outcomes. J Pediatr Surg (in press).
10. Dishop MK, McKay EM, Kreiger PA, et al. Fetal lung interstitial tumor (FLIT): a proposed newly recognized lung tumor of infancy to be differentiated from cystic pleuropulmonary blastoma and other developmental pulmonary lesions. Am J Surg Pathol 2010;34:1762-72.
11. Hill DA, Dishop MK, McKay EM, et al. Immature Interstitial Mesenchymal Tumor (IIMT): a distinctive new entity of the infant lung. Presented at the Annual Meeting of the Society for Pediatric Pathology, San Diego, CA, March 24-25; 2007.
12. Hill DA, Jarzembowski JA, Priest JR, et al. Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol 2008;32:282-95. (Pubitemid 351172144)
13. Kirsch S, Brecht IB, Dantonello T, et al. Sixteen children with pleuropulmonary blastoma: results of the cooperative soft tissue sarcoma group. Presented at the Sarcoma Meeting, Stuttgart, Germany; 2005.
14. Priest JR, Hill DA, Williams GM, et al. Type I pleuropulmonary blastoma: a report from the International Pleuropulmonary Blastoma Registry. J Clin Oncol 2006;24:4492-8. (Pubitemid 46630989)
15. Peranteau WH, Wilson RD, Liechty KW, et al. Effect of maternal betamethasone administration on prenatal congenital cystic adenomatoid malformation growth and fetal survival. Fetal Diagn Ther 2007;22:365-71. (Pubitemid 47267798)
16. Morris LM, Lim FY, Livingston JC, et al. High-risk fetal congenital pulmonary airway malformations have a variable response to steroids. J Pediatr Surg 2009;44:60-5.
17. Curran PF, Jelin EB, Rand L, et al. Prenatal steroids for microcystic congenital cystic adenomatoid malformations. J Pediatr Surg 2010;45:145-50.